COVID-19 Cases and Testing in 53 Prison Systems

Introduction

The United States (US) leads the world in both COVID-19 and mass incarceration. In the US, to date, there are 3,475,698 infections and 136,649 deaths in the US.¹ While the US has only 4% of the world’s population, it has a quarter of the world’s COVID-19 infections and deaths.^1,2 Simultaneously, the US has over a quarter of the world’s incarcerated population.³ Yet, these two public health emergencies do not exist in silos. COVID-19 has entered our country’s prisons, jails, and communities most impacted by mass incarceration at astounding rates.^4,5 In fact, jails and prisons have become epicenters of the pandemic with nine of the ten largest single site outbreaks occurring in correctional settings.

The confluence of mass incarceration and COVID-19 is not a coincidence. Disparities in social and structural determinants of health disproportionately impact racial minorities, those experiencing homelessness, and persons with substance use disorders or mental illness, all of whom are more likely to be incarcerated due to mass incarceration’s roots in racial inequities and discriminatory practices.^6,7 People who are incarcerated also have a higher burden of poor health outcomes making them more likely to suffer severely from COVID-19.⁷ Carceral settings themselves also amplify the risk of COVID with common prevention activities like social distancing being impossible to engage in due to dormitory style living conditions or overcrowding.⁷ In addition, the communities that people return home to and come into prisons from also bear a disproportionate burden of COVID-19. Black Americans are both overrepresented in the CJ system and are more likely to live in areas with higher poverty rates, have limited health care access, and have higher rates of jobs in service industries where they are less able to work from home, which increases exposure to COVID-19.^8,9

Policymakers, advocates, and academics have called for decarceration, specifically by increasing the number of compassionate releases, eliminating cash bail, and releasing those imprisoned for low-level crimes and misdemeanors.^7,10 However, prisons have yet to do this, instead relying on incremental measures such as suspending family and legal visits, distributing masks, and reducing the amount of time that people can spend recreating.¹¹ On average, prisons have only reduced their populations by 5%.¹² In the meantime, outbreaks have continued to occur in prisons throughout the country.

Given these outbreaks and the vulnerability of the imprisoned population, it is important that we comprehensively document the prevalence of COVID-19 within prisons. To do this, it is critical that we have systematic data on testing, test positivity, cases, and case fatality. While this is a pressing national issue, this data must be assessed at the state level as each state’s Department of Corrections collects data independently and independently determines their COVID policies. Additionally, each state’s general population has a different prevalence of COVID-19 infection and differing COVID policy (e.g., mandatory masks; stay-at-home orders), making the context surrounding this data unique to each state. In this paper, we present testing, infection, and fatality data by state, using novel data from the COVID Prison Project (CPP) on each state prison’s COVID data. We call for future research to build on CPP data to protect the health of our nations’ often forgotten residents.

Methods

Results

As of July 15, 2020, 10 states and Puerto Rico were reporting no testing information (Table 1). Of those that report testing numbers, testing varies widely with Hawaii testing 6 per 1,000 people who are incarcerated and Minnesota testing 1,531 per 1,000 people who are incarcerated, indicating an average of more than one test per incarcerated person. Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, Rhode Island, Tennessee, Texas, Vermont, West Virginia, and Wisconsin have all administered more than 500 tests per 1,000 incarcerated people, with Maryland, Massachusetts, Michigan, Minnesota, and Vermont having all administered more than one test per incarcerated person-indicating a universal testing effort in which all people currently incarcerated have had access to a COVID-19 test. The majority of prison systems have tested a higher proportion of their incarcerated population than the state’s general population. However, eleven prison systems are still testing fewer incarcerated people per 1,000 than their state’s general population.

Discussion

This analysis indicates that there is wide variation between testing and case rates in various prison systems and the general population. Previous research has estimated national prevalence of various state and federal prison systems.¹⁸ However, it is important to understand the COVID-19 pandemic and its impact on prison systems at a more granular level. For instance, when pooling low incidence prison settings with those in the middle of an outbreak disguises the local effect that COVID-19 is having on states and communities across the country. Our findings demonstrate that more often than not, more testing equals more cases identified, but uneven testing rates across the states make opaque a clear understanding of the extent of COVID-19 incidence in prison settings in several states.

Decarceration must remain a priority as it is the most effective way to prevent COVID-19 in carceral settings. In concert, though, prison systems should be the focus of robust testing efforts and be provided the resources to develop and deploy long-term testing strategies. The Centers for Disease Control and Prevention has indicated that asymptomatic testing in prison settings is warranted.¹⁹ A number of different testing strategies that should be implemented and studied relevant to their efficacy. These include: targeted testing (e.g. testing all new entrants, all transfers); public health surveillance testing (e.g. sampling a proportion of each facility or housing unit who are at high risk and testing them every month); and universal testing (repeat testing of all incarcerated people in predefined intervals over time). Not to be overlooked is the importance of implementing staff testing strategies as well.

Underlying this conversation is the need for updated, public information on COVID spread within our country’s prisons. This includes integrating data on COVID-related policies in prisons and their surrounding communities, keeping Departments of Corrections accountable by mapping their testing strategies to actual testing, and measuring the impact of decarceration, where it does occur, on COVID spread. As the pandemic of COVID persists, it is increasingly crucial that we collect and analyze this data to ultimately flatten the COVID-19 curve in prisons.

Conclusion

The two pandemics of mass incarceration and COVID are increasingly interconnected. COVID-19 cases are highly concentrated in prison systems. This study found that testing and case rates vary widely from state to state, but, overall, more testing leads to more case identification. To accurately assess COVID-19’s impact in the US prisons, it is urgently important to implement long-term testing strategies. It is only through implementing these strategies and continually documenting COVID testing, cases, and fatalities that we will know the spread of COVID in our prison and the injustices it has created and perpetuated.